Combining pharmacogenetics and patient characteristic polygenic scores to improve outcome prediction for Calcium Channel Blocker treatment
View ORCID ProfileDeniz Türkmen, Jack Bowden, Jane A.H. Masoli, View ORCID ProfileJoão Delgado, Chia-Ling Kuo, View ORCID ProfileLuke C. Pilling, David Melzer
doi: https://doi.org/10.1101/2023.02.10.23285767
Deniz Türkmen
1Epidemiology and Public Health Group, College of Medicine and Health, University of Exeter, Exeter, UK
Jack Bowden
2Exeter Diabetes Group (ExCEED), College of Medicine and Health, University of Exeter, Exeter, UK
3Department of Genetics, Novo Nordisk Research Centre Oxford, Innovation Building, Old Road Campus, Roosevelt Drive, Oxford, U.K
Jane A.H. Masoli
1Epidemiology and Public Health Group, College of Medicine and Health, University of Exeter, Exeter, UK
4Department of Healthcare for Older People, Royal Devon University Healthcare NHS Foundation Trust, Barrack Road, Exeter, UK
João Delgado
1Epidemiology and Public Health Group, College of Medicine and Health, University of Exeter, Exeter, UK
Chia-Ling Kuo
5UConn Center on Aging, University of Connecticut, Farmington, CT, USA
6Connecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut, CT, USA
Luke C. Pilling
1Epidemiology and Public Health Group, College of Medicine and Health, University of Exeter, Exeter, UK
David Melzer
1Epidemiology and Public Health Group, College of Medicine and Health, University of Exeter, Exeter, UK
Data Availability
The genetic and phenotypic UK Biobank data are available upon application to the UK Biobank (www.ukbiobank.ac.uk/register-apply).
Posted February 14, 2023.
Combining pharmacogenetics and patient characteristic polygenic scores to improve outcome prediction for Calcium Channel Blocker treatment
Deniz Türkmen, Jack Bowden, Jane A.H. Masoli, João Delgado, Chia-Ling Kuo, Luke C. Pilling, David Melzer
medRxiv 2023.02.10.23285767; doi: https://doi.org/10.1101/2023.02.10.23285767
Combining pharmacogenetics and patient characteristic polygenic scores to improve outcome prediction for Calcium Channel Blocker treatment
Deniz Türkmen, Jack Bowden, Jane A.H. Masoli, João Delgado, Chia-Ling Kuo, Luke C. Pilling, David Melzer
medRxiv 2023.02.10.23285767; doi: https://doi.org/10.1101/2023.02.10.23285767
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)